Strengthening Europe’s position in nanomedicine research requires concentrated action on common European research priorities in view of implementing joint initiatives. The Nanomedicine Strategic Research and Innovation Agenda gives a strategic and perspective frame for increasing uptake of nanomedical research and innovation through joint undertakings notably with large pharma or diagnostics companies, thereby contributing to the emergence of a nanomedicine industrial sector.Scope:
The proposed ERA-NET Cofund aims at coordinating the research efforts of the participating Member States, Associated States and Regions in the field of nanomedicine, continuing the activities started by the ERA-NET EuroNanoMed and fostering the competitiveness of European nanomedicine actors, and to implement a joint transnational call for proposals (resulting in grants to third parties) with EU co-funding to fund multinational innovative research initiatives in this domain.
The action will link with existing PPP or Joint programming initiatives such as IMI to leverage public funding and increase joint projects with Industries and to create a positive environment for the uptake of innovation nanomedicine.
The Commission considers that proposals requesting a contribution from the EU between EUR 8 and 10 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
No more than one action will be funded.Expected Impact: